Syd Labs In Vivo Grade Recombinant Anti-mouse PD-1 Mouse IgG2c-L234A L235A P329G (LALAPG) Kappa Monoclonal Antibody (Clone RMP1-14.1) (PA007162.m2cLA) . >$44/mg. For FC, IHC, neutralization, functional assays, bioanalytical PK and ADA assays, and those assays...
Syd Labs In Vivo Grade Recombinant Murinized Anti-mouse PD-1 Mouse IgG2c-L234A L235A P329G (LALAPG) Kappa Monoclonal Antibody (Clone RMP1-14.1), Endotoxin 0.05 EU/mg (PA007162.m2cLA.05). >$44/mg. For FC, IHC, neutralization, functional assays, bioanalytical PK and ADA assays,...
In vivo grade recombinant anti-mouse PD-1 mouse IgG2a-L234A L235A P329G (LALAPG) kappa monoclonal antibody (Clone 29F.1A12.1), Endotoxin 0.05 EU/mg, which share the same variable region sequences with the rat anti-mouse PD-1 / CD279 monoclonal antibody...
What is the difference among PA007162.r2a, PA007162.m2cLA, and PA007162.mm2cLA? Syd Labs further murinize the antibody variable region sequences of PA007162.m2cLA to produce PA007162.mm2cLA.
What is the difference among PA007162.r2a, PA007162.m2cLA, and PA007162.mm2cLA? Syd Labs further murinize the antibody variable region sequences of PA007162.m2cLA to produce PA007162.mm2cLA.
Atezolizumab Biosimilar, Human IgG1. The research grade Atezolizumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Atezolizumab but not durvalumab binds and blocks mouse PD-L1.
Atezolizumab Biosimilar, Mouse IgG2a. The research grade Atezolizumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Atezolizumab but not durvalumab binds and blocks mouse PD-L1.
Atezolizumab Biosimilar, Mouse IgG1. The research grade Atezolizumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Atezolizumab but not durvalumab binds and blocks mouse PD-L1.
Atezolizumab Biosimilar, Endotoxin 0.05 EU/mg. The research grade Atezolizumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Atezolizumab but not durvalumab binds and blocks mouse PD-L1.
